9 May - 10 May 2023

Kinase 2023: 10th SCI / RSC Symposium on Kinase Inhibitor Design

Organised by:

SCI's Fine Chemicals Group and RSC’s Biological and Medicinal Chemistry Sector

SCI, London, UK

Register your interest
Synopsis

With more than 70 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 10th SCI/RSC symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.


Attendees

This event is aimed at all scientists interested in furthering their knowledge of kinases. It will also have wider appeal to members of the drug discovery community eager to understand how enzyme inhibitor programmes are approached and executed across the pharmaceutical industry.

This event will bring together industrial and academic experts representing many of the leading institutions in kinase drug discovery, to discuss a selection of new and emerging topics within the fields of kinase therapeutics for oncology and non-oncology therapies, and foster discussions within the wider industry through networking events such as poster sessions and industrial exhibitions.


Sponsorship

For further information and prices, please email conferences@soci.org.


Programme

The programme will be confirmed in due course.


Venue and Contact

SCI

14/15 Belgrave Square
London
SW1X 8PS

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Fees
The fees will be announced in due course.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Booking Process/Deadlines

Booking terms and conditions


Organising committee
Stuart Cameron, Malvern Panalytical
John Cumming, F Hoffmann-La Roche
Ray Finlay, AstraZeneca
John Harris, CJH Consultants
Pascal Savy, Charles River Laboratories
Douglas Williamson, Transition Bio